Stocks and Investing Stocks and Investing
Fri, August 11, 2023

Gregory Renza Maintained (APTO) at Buy with Decreased Target to $23 on, Aug 11th, 2023


Published on 2024-10-28 05:50:56 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $40 to $23 on, Aug 11th, 2023.

Gregory has made no other calls on APTO in the last 4 months.



There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory


  • Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $38 on, Monday, June 12th, 2023
Contributing Sources